Thus, in this study we investigated the effects of sMD-2 and sCD14 on the growth of both Gram-negative and Gram-positive bacteria. E. coli O111:B4 LPS (Sigma-Aldrich, St Louis, MO, USA) was re-purified according to Hirschfeld et al. (20). PG from Bacillus subtilis (Sigma-Aldrich) was confirmed to possess no TLR4-stimulatory activity up to 10 μg/ml. Unless otherwise noted, all other chemicals were from Wako Pure Chemical Industries (Osaka, Japan). The coding region of human MD-2 lacking its signal

sequence was amplified by PCR from pEIAV-hMD-2 as described previously (21) and subcloned into the yeast expression vector pGAPZα (Invitrogen, Carlsbad, CA, USA) with an N-terminal 6× histidine Everolimus tag sequence, resulting in plasmid pGAPZα-hMD-2. The coding region of human CD14 lacking its signal sequence and the sequence encoding the eight C-terminal amino acids (22) was subcloned into pGAPZα GPCR Compound Library order with an N-terminal 6× histidine tag sequence, resulting in plasmid pGAPZα-hCD14. A plasmid encoding a CD14 mutant lacking amino acids 57 to 64 was generated by PCR from pGAPZα-hCD14 using primers 5′-GACACGGTCAAGGCTCTC-3′ and 5′-CGCATCGACGCGCTTTAG-3′. The deletion was confirmed by automated DNA sequencing. Human MD-2 and CD14 in yeast were purified as previously described (7). pGAPZα-hMD-2

and pGAPZα-hCD14 were expressed in a Pichia expression system (Invitrogen) and purified with a Ni2+-column (Novagen, Madison, WI, USA) under denaturing conditions according to the manufacturer’s recommendations. E. coli DH5α (Invitrogen) and B. subtilis NBRC3134 were inoculated in LB broth and bacillus broth (10 g/l polypeptone, 2 g/l yeast extract, 1 g/l MgSO4·7H2O,

http://www.selleck.co.jp/products/cetuximab.html pH 7.0), respectively and incubated at 37°C for 18 hr. After incubation, each culture was diluted to 2 × 105 CFU/ml for E. coli and 4 × 104 CFU/ml for B. subtilis with phenol red-free DMEM (Gibco, Eggenstein, Germany). Either sMD-2 or sCD14 (0.25–1 μg/ml each) was added to the culture, and myosin (Sigma-Aldrich; 1 μg/ml), which had been confirmed to have no effects on bacterial growth, was added as a control. These were cultured at 37°C for up to 18 hr. The number of viable cells was measured by plating cultures on either LB agar for E. coli or bacillus broth agar for B. subtilis and counting the number of colonies (CFU/ml). The viability of bacteria was also measured using the MTS assay in the CellTiter 96 AQueous One Solution Cell Proliferation Assay kit (Promega, Madison, WI, USA) according to the manufacturer’s recommendations. Wells in 96-well plates were coated with PG (250 pg/ml) in PBS at 37°C for 3 hr. After washing five times with PBST, the wells were blocked by incubating with 0.2% BSA (Sigma-Aldrich) in PBS at 4°C overnight. After five washes with PBST, either His-tagged sMD-2 or sCD14 was added at the indicated concentration, and the plates incubated at 37°C for 1 hr.